Tag: Barostim
Barostim neuromodulation device misses primary endpoint in BEAT-HF trial
CVRx has announced the preliminary topline results of the BEAT-HF (Baroreflex activation therapy for heart failure) postmarket clinical trial.
The BEAT-HF postmarket phase of the...
CVRx launches new version of neuromodulation device intended to treat heart...
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodulation device to treat the symptoms of heart failure—has launched its new...
US physicians “among nation’s first” to implant neurostimulator technology for advanced...
Doctors at St David's Medical Center in Austin, USA recently implanted a new neurostimulator technology in patients to help treat advanced heart failure—and are...
